{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:15:38Z","timestamp":1794374138754,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,8,17]],"date-time":"2003-08-17T00:00:00Z","timestamp":1061078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,8,17]],"date-time":"2003-08-17T00:00:00Z","timestamp":1061078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2003,9,1]]},"DOI":"10.1038\/nm917","type":"journal-article","created":{"date-parts":[[2003,8,18]],"date-time":"2003-08-18T10:29:37Z","timestamp":1061202577000},"page":"1131-1137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":831,"title":["Duration of antiviral immunity after smallpox vaccination"],"prefix":"10.1038","volume":"9","author":[{"given":"Erika","family":"Hammarlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa I","family":"Strelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M","family":"Hanifin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K","family":"Slifka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,8,17]]},"reference":[{"key":"BFnm917_CR1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","volume":"283","author":"DA Henderson","year":"1999","unstructured":"Henderson, D.A. The looming threat of bioterrorism. Science 283, 1279\u20131282 (1999).","journal-title":"Science"},{"key":"BFnm917_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3201\/eid0706.010607","volume":"7","author":"MI Meltzer","year":"2001","unstructured":"Meltzer, M.I., Damon, I., LeDuc, J.W. & Millar, J.D. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg. Infect. Dis. 7, 959\u2013969 (2001).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnm917_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/414748a","volume":"414","author":"R Gani","year":"2001","unstructured":"Gani, R. & Leach, S. Transmission potential of smallpox in contemporary populations. Nature 414, 748\u2013751 (2001).","journal-title":"Nature"},{"key":"BFnm917_CR4","doi-asserted-by":"publisher","first-page":"10935","DOI":"10.1073\/pnas.162282799","volume":"99","author":"EH Kaplan","year":"2002","unstructured":"Kaplan, E.H., Craft, D.L. & Wein, L.M. Emergency response to a smallpox attack: the case for mass vaccination. Proc. Natl. Acad. Sci. USA 99, 10935\u201310940 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm917_CR5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1086\/339909","volume":"34","author":"T O'Toole","year":"2002","unstructured":"O'Toole, T., Mair, M. & Inglesby, T.V. Shining light on \u201cDark Winter\u201d. Clin. Infect. Dis. 34, 972\u2013983 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm917_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri845","volume":"2","author":"GL Smith","year":"2002","unstructured":"Smith, G.L. & McFadden, G. Science and society. Smallpox: anything to declare? Nat. Rev. Immunol. 2, 521\u2013527 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm917_CR7","volume-title":"The Pathogenesis, Immunology, and Pathology of Smallpox and Vaccinia","author":"F Fenner","year":"1988","unstructured":"Fenner, F., Henderson, D.A., Arita, I., Jezek, Z. & Ladnyi, I.D. in The Pathogenesis, Immunology, and Pathology of Smallpox and Vaccinia (World Health Organization, Geneva, 1988)."},{"key":"BFnm917_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","volume":"21","author":"TM Mack","year":"1972","unstructured":"Mack, T.M., Noble, J. Jr & Thomas, D.B. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Med. Hyg. 21, 214\u2013218 (1972).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm917_CR9","first-page":"307","volume":"52","author":"JK Sarkar","year":"1975","unstructured":"Sarkar, J.K., Mitra, A.C. & Mukherjee, M.K. The minimum protective level of antibodies in smallpox. Bull. World Health Organ. 52, 307\u2013311 (1975).","journal-title":"Bull. World Health Organ."},{"key":"BFnm917_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1017\/S0022172400037980","volume":"56","author":"AW Downie","year":"1958","unstructured":"Downie, A.W. & McCarthy, K. The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox. J. Hyg. 56, 479\u2013487 (1958).","journal-title":"J. Hyg."},{"key":"BFnm917_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4049\/jimmunol.164.1.208","volume":"164","author":"MK Slifka","year":"2000","unstructured":"Slifka, M.K. & Whitton, J.L. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164, 208\u2013216 (2000).","journal-title":"J. Immunol."},{"key":"BFnm917_CR12","first-page":"63","volume":"19","author":"G Nyerges","year":"1972","unstructured":"Nyerges, G., Hollos, I., Losonczy, G., Erdos, L. & Petras, G. Development of vaccination immunity in hospital personnel revaccinated at three-year intervals. Acta Microbiol. Acad. Sci. Hung. 19, 63\u201368 (1972).","journal-title":"Acta Microbiol. Acad. Sci. Hung."},{"key":"BFnm917_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","volume":"161","author":"B el-Ad","year":"1990","unstructured":"el-Ad, B. et al. The persistence of neutralizing antibodies after revaccination against smallpox. J. Infect. Dis. 161, 446\u2013448 (1990).","journal-title":"J. Infect. Dis."},{"key":"BFnm917_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20022222","volume":"197","author":"M Terajima","year":"2003","unstructured":"Terajima, M. et al. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med. 197, 927\u2013932 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm917_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0022-1759(02)00025-X","volume":"262","author":"SA Speller","year":"2002","unstructured":"Speller, S.A. & Warren, A.P. Ex vivo detection and enumeration of human antigen-specific CD8+ T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining. J. Immunol. Methods 262, 167\u2013180 (2002).","journal-title":"J. Immunol. Methods"},{"key":"BFnm917_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1017\/S0022172400037979","volume":"56","author":"K McCarthy","year":"1958","unstructured":"McCarthy, K. & Downie, A.W. The antibody response in man following infection with viruses of the pox group. II. Antibody response following vaccination. J. Hyg. 56, 466\u2013478 (1958).","journal-title":"J. Hyg."},{"key":"BFnm917_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0264-410X(98)00197-2","volume":"17","author":"S Stienlauf","year":"1999","unstructured":"Stienlauf, S. et al. Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination. Vaccine 17, 201\u2013204 (1999).","journal-title":"Vaccine"},{"key":"BFnm917_CR18","unstructured":"Centers for Disease Control. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization practices (ACIP). Morb. Mortal. Wkly. Rep. 50, 1\u201325 (2001)."},{"key":"BFnm917_CR19","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","volume":"289","author":"SE Frey","year":"2003","unstructured":"Frey, S.E., Newman, F.K., Yan, L. & Belshe, R.B. Response to smallpox vaccine in persons immunized in the distant past. J. Am. Med. Assoc. 289, 3295\u20133299 (2003).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm917_CR20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa013431","volume":"346","author":"SE Frey","year":"2002","unstructured":"Frey, S.E. et al. Dose-related effects of smallpox vaccine. N. Engl. J. Med. 346, 1275\u20131280 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnm917_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1086\/340517","volume":"185","author":"FA Ennis","year":"2002","unstructured":"Ennis, F.A., Cruz, J., Demkowicz, W.E. Jr, Rothman, A.L. & McClain, D.J. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-\u03b3-producing T cells after smallpox vaccination. J. Infect. Dis. 185, 1657\u20131659 (2002).","journal-title":"J. Infect. Dis."},{"key":"BFnm917_CR22","unstructured":"CDC. Smallpox - Stockholm, Sweden, 1963. Morb. Mortal. Wkly. Rep. 12, 172, 174\u2013176, 183, 188, 191, 220, 236 (1963)."},{"key":"BFnm917_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/infdis\/125.2.161","volume":"125","author":"TM Mack","year":"1972","unstructured":"Mack, T.M. Smallpox in Europe, 1950\u20131971. J. Infect. Dis. 125, 161\u2013169 (1972).","journal-title":"J. Infect. Dis."},{"key":"BFnm917_CR24","volume-title":"The value of vaccination as shown by an analysis of 10,403 cases of smallpox","author":"W Gayton","year":"1885","unstructured":"Gayton, W. in The value of vaccination as shown by an analysis of 10,403 cases of smallpox (Gillett & Henty, London, 1885)."},{"key":"BFnm917_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-191310000-00015","volume-title":"Studies in smallpox and vaccination","author":"W Hanna","year":"1913","unstructured":"Hanna, W. in Studies in smallpox and vaccination (William Wood and Company, New York, 1913)."},{"key":"BFnm917_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/rmv.361","volume":"12","author":"W Hanna","year":"2002","unstructured":"Hanna, W. & Baxby, D. Studies in smallpox and vaccination. 1913. Rev. Med. Virol. 12, 201\u2013209 (2002).","journal-title":"Rev. Med. Virol."},{"key":"BFnm917_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/oxfordjournals.aje.a121319","volume":"94","author":"GG Heiner","year":"1971","unstructured":"Heiner, G.G. et al. A study of inapparent infection in smallpox. Am. J. Epidemiol. 94, 252\u2013268 (1971).","journal-title":"Am. J. Epidemiol."},{"key":"BFnm917_CR28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1542\/peds.26.2.176","volume":"25","author":"CH Kempe","year":"1960","unstructured":"Kempe, C.H. Studies on smallpox and complications of smallpox vaccination. Pediatrics 25, 176\u2013189 (1960).","journal-title":"Pediatrics"},{"key":"BFnm917_CR29","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1099\/0022-1317-71-10-2341","volume":"71","author":"CP Czerny","year":"1990","unstructured":"Czerny, C.P. & Mahnel, H. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies. J. Gen. Virol. 71 (Pt. 10), 2341\u20132352 (1990).","journal-title":"J. Gen. Virol."},{"key":"BFnm917_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/viro.1998.9516","volume":"254","author":"MC Galmiche","year":"1999","unstructured":"Galmiche, M.C., Goenaga, J., Wittek, R. & Rindisbacher, L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology 254, 71\u201380 (1999).","journal-title":"Virology"},{"key":"BFnm917_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","volume":"83","author":"JC Ramirez","year":"2002","unstructured":"Ramirez, J.C., Tapia, E. & Esteban, M. Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions. J. Gen. Virol. 83, 1059\u20131067 (2002).","journal-title":"J. Gen. Virol."},{"key":"BFnm917_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1084\/jem.145.3.644","volume":"145","author":"RM Zinkernagel","year":"1977","unstructured":"Zinkernagel, R.M. & Althage, A. Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J. Exp. Med. 145, 644\u2013651 (1977).","journal-title":"J. Exp. Med."},{"key":"BFnm917_CR33","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.4049\/jimmunol.166.3.1690","volume":"166","author":"M Derby","year":"2001","unstructured":"Derby, M., Alexander-Miller, M., Tse, R. & Berzofsky, J. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 166, 1690\u20131697 (2001).","journal-title":"J. Immunol."},{"key":"BFnm917_CR34","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","volume":"168","author":"V Appay","year":"2002","unstructured":"Appay, V. et al. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 168, 5954\u20135958 (2002).","journal-title":"J. Immunol."},{"key":"BFnm917_CR35","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.4049\/jimmunol.170.4.2205","volume":"170","author":"F Yanai","year":"2003","unstructured":"Yanai, F. et al. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J. Immunol. 170, 2205\u20132213 (2003).","journal-title":"J. Immunol."},{"key":"BFnm917_CR36","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/jvi.66.4.2274-2280.1992","volume":"66","author":"RA Littaua","year":"1992","unstructured":"Littaua, R.A., Takeda, A., Cruz, J. & Ennis, F.A. Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. J. Virol. 66, 2274\u20132280 (1992).","journal-title":"J. Virol."},{"key":"BFnm917_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1099\/0022-1317-74-4-751","volume":"74","author":"AL Erickson","year":"1993","unstructured":"Erickson, A.L. & Walker, C.M. Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans. J. Gen. Virol. 74, 751\u2013754 (1993).","journal-title":"J. Gen. Virol."},{"key":"BFnm917_CR38","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.70.4.2627-2631.1996","volume":"70","author":"WEJ Demkowicz","year":"1996","unstructured":"Demkowicz, W.E.J., Littaua, R.A., Wang, J. & Ennis, F.A. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70, 2627\u20132631 (1996).","journal-title":"J. Virol."},{"key":"BFnm917_CR39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.139.4.988","volume":"139","author":"JM Zarling","year":"1987","unstructured":"Zarling, J.M. et al. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J. Immunol. 139, 988\u2013990 (1987).","journal-title":"J. Immunol."},{"key":"BFnm917_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJMra020025","volume":"346","author":"JG Breman","year":"2002","unstructured":"Breman, J.G. & Henderson, D.A. Diagnosis and management of smallpox. N. Engl. J. Med. 346, 1300\u20131308 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnm917_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF02121136","volume":"166","author":"LH Perrin","year":"1978","unstructured":"Perrin, L.H., Reynolds, D., Zinkernagel, R. & Oldstone, M.B. Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus. Med. Microbiol. Immunol. (Berl.) 166, 71\u201379 (1978).","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"BFnm917_CR42","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1084\/jem.146.4.949","volume":"146","author":"LH Perrin","year":"1977","unstructured":"Perrin, L.H., Zinkernagel, R.M. & Oldstone, M.B. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes. J. Exp. Med. 146, 949\u2013969 (1977).","journal-title":"J. Exp. Med."},{"key":"BFnm917_CR43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","volume":"18","author":"CH Kempe","year":"1956","unstructured":"Kempe, C.H., Berge, T.O. & England, B. Hyperimmune vaccinial \u03b3 globulin. Pediatrics 18, 177 (1956).","journal-title":"Pediatrics"},{"key":"BFnm917_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(58)90351-9","volume":"2","author":"ER Peirce","year":"1958","unstructured":"Peirce, E.R., Melville, F.S., Downie, A.W. & Duckworth, M.J. Antivaccinial \u03b3-globulin in smallpox prophylaxis. Lancet 2, 635\u2013638 (1958).","journal-title":"Lancet"},{"key":"BFnm917_CR45","first-page":"41","volume":"25","author":"CH Kempe","year":"1961","unstructured":"Kempe, C.H. et al. The use of vaccinia hyperimmune \u03b3-globulin in the prophylaxis of smallpox. Bull World Health Organ. 25, 41\u201348 (1961).","journal-title":"Bull World Health Organ."},{"key":"BFnm917_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0966-842X(96)10059-7","volume":"4","author":"MK Slifka","year":"1996","unstructured":"Slifka, M.K. & Ahmed, R. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 4, 394\u2013400 (1996).","journal-title":"Trends Microbiol."},{"key":"BFnm917_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJM200208293470913","volume":"347","author":"JA Frelinger","year":"2002","unstructured":"Frelinger, J.A. & Garba, M.L. How durable are the immune responses after smallpox vaccination? N. Engl. J. Med. 347, 689\u2013690 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnm917_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-1759(96)00146-9","volume":"199","author":"MK Slifka","year":"1996","unstructured":"Slifka, M.K. & Ahmed, R. Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay. J. Immunol. Meth. 199, 37\u201346 (1996).","journal-title":"J. Immunol. Meth."},{"key":"BFnm917_CR49","first-page":"515","volume":"42","author":"SG Anderson","year":"1970","unstructured":"Anderson, S.G. & Skegg, J. The international standard for anti-smallpox serum. Bull. World Health Organ. 42, 515\u2013523 (1970).","journal-title":"Bull. World Health Organ."},{"key":"BFnm917_CR50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4049\/jimmunol.85.3.275","volume":"85","author":"E Cutchins","year":"1960","unstructured":"Cutchins, E., Warren, J. & Jones, W.P. The antibody response to smallpox vaccination as measured by a tissue culture plaque technique. J. Immunol. 85, 275\u2013283 (1960).","journal-title":"J. Immunol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm917","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:09:18Z","timestamp":1744344558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,17]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9,1]]}},"alternative-id":["BFnm917"],"URL":"https:\/\/doi.org\/10.1038\/nm917","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,17]]},"assertion":[{"value":"13 May 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}